| 000 | 01553 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516200138.0 | ||
| 264 | 0 | _c20141022 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1559-131X | ||
| 024 | 7 |
_a10.1007/s12032-014-0882-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Qiang | |
| 245 | 0 | 0 |
_aExpression of chemokine receptor 4 was associated with poor survival in renal cell carcinoma. _h[electronic resource] |
| 260 |
_bMedical oncology (Northwood, London, England) _cApr 2014 |
||
| 300 |
_a882 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aKidney Neoplasms _xgenetics |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aReceptors, CCR4 _xgenetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRexiati, Mulati | |
| 700 | 1 | _aYang, Ying | |
| 700 | 1 | _aWang, Wen-Guang | |
| 700 | 1 | _aAzhati, Baihetiya | |
| 700 | 1 | _aSaimaiti, Weilijiang | |
| 700 | 1 | _aWang, Yu-Jie | |
| 773 | 0 |
_tMedical oncology (Northwood, London, England) _gvol. 31 _gno. 4 _gp. 882 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12032-014-0882-y _zAvailable from publisher's website |
| 999 |
_c23571845 _d23571845 |
||